SUMMIT European Cannabis Insights Summit 2026 — Exclusive industry intelligence Register Now
EVENT Cannabis Europa London 2026 — Europe's cannabis industry unites Get Tickets

Recent Searches

    UK cannabis market could be worth over £1bn by 2026

    By
    Home / UK cannabis market could be worth over £1bn by 2026

    Industry leaders are urging the Government to embrace the industry, as new analysis shows the UK cannabis market could be worth over £1bn in the UK by 2026.

    New analysis from Prohibition Partners shows the UK cannabis market could grow to over £1bn by 2026.

    The analysis emphasises that if the UK were to fully legalise cannabis this year – with recreational sales beginning in 2024 – the sector could be worth over £627m by 2026, bringing the market’s total size to the £1bn mark in the UK alone.

    This growth could see the cannabis industry play a significant role in boosting economic growth in the UK, says Prohibition Partners, both through significant levels of foreign direct investment into the UK, and through job creation across the UK, supporting the Government’s ‘Levelling Up’ ambitions.

    Read more: Germany’s legalisation push has lit up the European cannabis market

    CEO and co-founder of Prohibition Partners, Stephen Murphy, said: “The genie is out of the bottle with the cannabis industry – North America has embraced it, and Europe is starting to. 

    “The sector has shown it can deliver huge levels of investment, economic growth and jobs for economies that embrace it.

    “The UK now has to ensure it isn’t left behind as investors turn toward Europe as the next frontier of the cannabis industry. At a time when the UK sorely needs similar economic boosts, going green and backing cannabis will deliver for the UK economy.”

    European countries such as Germany, Denmark and Portugal are already cashing in on the burgeoning industry, and are reaping the economic benefits. In 2021, close to £500m of capital assets were held in Europe by just a few of the largest North American firms, representing a large injection of significant foreign direct investment into the industry.

    Further research from Prohibition Partners has calculated the medical and adult-use sectors are set for a ‘green gold-rush’ in Europe, to be worth up to £3.2bn by 2026 if adult-use legalisation progresses in Germany as forecasted.

    The organisation has highlighted that a number of steps are needed for the UK to fully unlock the cannabis industry, including allowing cannabis medicines to be prescribed by NHS doctors and covered by public health insurance, and the reform of adult-use cannabis regulations in line with advances being made in places such as Germany. 

    Evidence from North America shows that legalising cannabis can provide huge benefits to a nation’s economy – since Canada legalised recreational cannabis in 2018, the industry has contributed $43.5bn to the country’s GDP, whilst creating 98,000 jobs.

    Industry leaders are making the call for the UK to embrace the sector as s Prohibition Partners prepares to host Cannabis Europa, Europe’s leading cannabis conference, in London on 28 to 29 June. 

    More than 1500 delegates are expected to attend from over 25 countries. The conference – with delegates including rapper Big Narstie and Snoop Dogg’s Venture Capital fund – will bring together activists, academics and advocates from the industry to talk about the growth of the medical and recreational markets in Europe, and the investment opportunities attached to these growing industries.

    The conference will also explore how these regulatory and legislative barriers can be overcome, to unlock the benefits of the cannabis industry for the UK.

    [activecampaign form=31]

    10 June 2026 · Berlin Sales end May 29

    European Cannabis
    Insights Summit

    From €216

    200+ industry leaders. Exclusive German market data. A half-day briefing for B2B operators in Europe's most important emerging cannabis market.

    Stephanie Price

    Stephanie is a journalist for Business of Cannabis, writing about science, research, policy and industry developments in cannabis, CBD and psychedelics. In 2013 Stephanie gained her BA in English and Media, focusing on journalism and propaganda, where her magazine ‘Game Theory’ focused on developments and disruptors over the coming decade including cannabis, psychedelics, blockchain/crypto and free speech. In 2015 Stephanie received her National Council for the Training of Journalists (NCTJ) diploma whilst working as a reporter in North Wales. Stephanie has a specialism in Medical Cannabis: The Health Effects of THC and CBD through the University of Colorado, and a certificate from the Medical Cannabis Clinicians Society on “Medical Cannabis Explained”.

    The Briefing / Newsletter

    Insights
    you don't want
    to miss.

    A comprehensive, thoughtfully curated overview of the stories defining today's cannabis sector — breaking news, investigative features, expert commentary, and context-rich analysis to help you navigate events with clarity and confidence.

    • Policy & regulation
    • Markets & deals
    • Clinical & science
    Subscribe free